Excitement is building over remdesivir as a treatment for COVID-19. On Friday, the Food and Drug Administration authorized the emergency use of remdesivir to treat COVID-19, President Trump announced.

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Remdesivir treatment is associated with reduced ...

Please provide your email address to receive an email when new articles are posted on . Remdesivir did not reduce adverse cardiovascular or kidney events in the study cohort. Remdesivir use was ...

The World Health Organization has updated its ongoing guidance on Covid-19 medications to advise against using the antiviral drug remdesivir to treat hospitalized patients, no matter how severe their ...

U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir since July as need for the costly antiviral wanes, the Department of Health and Human Services ...

A 25% lower all-cause mortality is associated with timely initiation of remdesivir in immunocompromised patients hospitalized for COVID-19. Among patients with immunocompromising conditions who were ...

Researchers released some good news about a possible treatment for coronavirus Wednesday -- evidence that the experimental drug remdesivir might help patients recover more quickly from the infection.

The FDA expanded remdesivir’s emergency use authorization to allow for all hospitalized COVID-19 patients, regardless of case severity, to be treated with the drug. The FDA granted emergency use ...

– If Granted by the European Commission, Veklury will become the First and Only Authorized Antiviral Treatment Across All Stages of Renal Disease – In Europe, approximately 75 million people suffer ...